ThePICenter.com: A Nationwide Network of Legal Representation for Accidents and Injuries Home | Refer to a Friend | Contact Us | Attorney Log-In
ThePICenter - The Personal Injury Center  

Call us today: 877.888.5936 
 Cases We Handle  Why Choose Us  About Us  Client Services  Frequently Asked Questions   Free Case Evaluation - Submit Your Case
Seroquel
Has Seroquel Caused You Or A Loved One Harm?
Fill Out The Form Below For A Free Evaluation
 
Areas of Expertise
Accidents
Consumer Fraud
Medical Malpractice
Toxic Substances
Unsafe Drugs
Unsafe Products
 
Have a case, but would like to speak with us directly?
 
Call us today: 877.888.5936
 
Click here to receive your free evaluation
 
Unsafe Drugs :: Seroquel

SEROQUEL - WE ARE NO LONGER ACCEPTING SEROQUEL INQUIRIES OR CASES!

In 1997, Seroquel was approved by the FDA to treat individuals suffering from schizophrenia and bipolar disorder. However, it was often prescribed to treat "off-label" disorders as well like autism and dementia thanks in large part to the manufacturer, AstraZeneca (NYSE: AZN), promoting these unapproved, "off-label" uses.

Beginning in 2003, the FDA began to take notice of reports of hyperglycemia and diabetes occuring at an alarming rate in patients that had been prescribed Seroquel. Subsequently, in 2004, the FDA required AstraZeneca to add a label warning of these serious side effects.

In 2005, Seroquel was finally required to carry a black box warning, the FDA's highest such safety warning, after a clinical study found that when Seroquel was prescribed for dementia, which is not an approved use of the drug, the mortality rate is considerably higher in patients that are given Seroquel than those patients given a placebo.

The reason why this is a concern is that AstraZeneca was using false and misleading promotional material leading to the drug being used for conditions for which it was not intended nor approved by the FDA. In fact, the FDA issued a warning letter to AstraZeneca asserting that the company not only used misleading marketing material, but also failed to make doctors and patients aware of the side effects.

As mentioned above, diabetes and hyperglycemia are the two leading side effects associated with this drug whether it was prescribed for approved uses or not. But there is also the risk of heart failure or sudden death, especially when taken for "off-label" uses. We believe that AstraZeneca only exacerbated the problem by marketing this defective and unsafe drug for conditions it was never supposed to treat.

Their defective drug not only harmed the people for whom it was intended, but also thousands of others due to their deceptive and outlandish marketing. We intend to hold them accountable for their negligent actions. 

Unsafe drug cases are complex and costly to litigate.  Experienced representation is essential, and that is exactly what we help provide.  If you believe you or a loved one suffered a serious complication as a result of using Seroquel, please fill out the form below for a free evaluation.
 
Keywords: Seroquel Lawsuit | Seroquel Lawyers | Seroquel Attorneys | Seroquel Lawyer | Seroquel Attorney
 



Free Case Evaluation

Use the form below to submit your case and receive a free evaluation. By submitting this form, you certify that you agree to our Terms and Conditions and want us to contact you regarding your inquiry. Required fields are marked in BOLD.

Your Name:
Your Address:
Your City:
Your State:
Your Zipcode:
Your Email:
Your Phone Number:
Your Fax Number:
Date of Injury:  
Location of Injury:  
If this inquiry is not for yourself, please tell us the name of the person injured:
Your relationship to this person:
 
Details of Injury:
   
Enter the code shown:

Please note, this form may take a few seconds to process after the Submit Case button is pressed.
 


Seroquel In the News

FDA talks, but doctors don't necessarily listen - FiercePharma
FDA talks, but doctors don't necessarily listenFiercePharmaWhen the FDA recommended that patients using atypical antipsychotics--such as Eli Lilly's ($LLY) Zyprexa and AstraZeneca's ($AZN) Seroquel--be monitored...
More Information »



FDA Panel: Oral Single-Agent Levonorgestrels Safe in Teens - Medscape
FDA Panel: Oral Single-Agent Levonorgestrels Safe in TeensMedscapeFebruary 2, 2012 — In a pediatric-focused safety review, the US Food and Drug Administration (FDA) Pediatric Advisory Committee recommended that levonorgestrel...
More Information »



AstraZeneca to Buy Back $4.5 Billion in Stock, Cut Jobs as Patents Expire - Bloomberg
BloombergAstraZeneca to Buy Back $4.5 Billion in Stock, Cut Jobs as Patents ExpireBloombergEnlarge image AstraZeneca to Buy Back $4.5 Billion in Stock, Cut More Jobs AstraZeneca to Buy Back $4.5 Billion in Stock, Cut More...
More Information »



FDA Panel Says Omalizumab Safe in Pediatric Patients - Medscape
FDA Panel Says Omalizumab Safe in Pediatric PatientsMedscapeJanuary 31, 2012 — In a pediatric-focused safety review, the US Food and Drug Administration (FDA) Pediatric Advisory Committee Panel recommended yesterday that...
More Information »



AstraZeneca Declines Most in 5 Months on Forecast: London Mover - BusinessWeek
AstraZeneca Declines Most in 5 Months on Forecast: London MoverBusinessWeekPatent protection on the drugmaker's best-selling medicines, including the ulcer treatment Nexium and antipsychotic medication Seroquel, expires...
More Information »



Prevnar 13 Should Be Watched for Febrile Seizure Risk - Medscape
Prevnar 13 Should Be Watched for Febrile Seizure RiskMedscapeJanuary 31, 2012 — The US Food and Drug Administration (FDA) Pediatric Advisory Committee today reviewed safety data on pneumococcal 13-valent conjugate vaccine...
More Information »



FDA requiring more data, possibly new studies before ruling on Bristol-Astra ... - Washington Post
The Star-Ledger - NJ.comFDA requiring more data, possibly new studies before ruling on Bristol-Astra ...Washington PostThe Food and Drug Administration decision Thursday comes after expert FDA advisers in July recommended...
More Information »



A father's anguish: Military killed my son with prescription pad - Daily Caller
Daily CallerA father's anguish: Military killed my son with prescription padDaily CallerSeroquel has been on the market since 1997, and in that time doctors have widely experimented with prescribing it for “off-label”...
More Information »



Pancrelipases, Xerese Cream Returned for Routine Monitoring - Medscape
Pancrelipases, Xerese Cream Returned for Routine MonitoringMedscapeJanuary 30, 2012 — Three forms of pancrelipase and an acyclovir/hydrocortisone cream were recommended for return to routine monitoring during an abbreviated...
More Information »



FDA Delays Approval Of AstraZeneca, Bristol-Myers Squibb Drug (NYSE: AZN ... - LocalizedUSA
FDA Delays Approval Of AstraZeneca, Bristol-Myers Squibb Drug (NYSE: AZN ...LocalizedUSAAstraZeneca and Bristol-Myers Squibb have announced that they are working with the FDA to determine their next steps and are in ongoing...
More Information »



Can AstraZeneca continue to swear off major M&A? - FiercePharma
Philadelphia InquirerCan AstraZeneca continue to swear off major M&A?FiercePharmaNow, what's going to take the place of, say, Seroquel sales if not some bought-in products? Brennan has reiterated his "no...
More Information »



Data show link between diabetes and psych drug - Bennington Banner
Data show link between diabetes and psych drugBennington BannerThe federal Food and Drug Administration required manufacturers of the five drugs included in the state review, plus another atypical antipsychotic, Seroquel, to...
More Information »



America's Mental Health Industry Is a Threat to Our Sanity - truthout
truthoutAmerica's Mental Health Industry Is a Threat to Our SanitytruthoutBy the time Rebecca was three years old, again based mainly on parental complaints, Kifuji had given Rebecca an additional diagnosis of bipolar...
More Information »



EARNINGS PREVIEW: New Drugs, FX Key For Europe Pharma Earnings - NASDAQ
EARNINGS PREVIEW: New Drugs, FX Key For Europe Pharma EarningsNASDAQMARKET EXPECTATIONS: The Anglo-Swedish drug maker, which reports in US dollars, faces crucial patent expiries between 2011-2015 such as Seroquel and Nexium,...
More Information »

 









 
Aviation Accidents| Car Accidents| Truck Accidents| Birth Injuries| Nursing Home Negligence| Mesothelioma| Defective Medical Devices
Copyright 2011 Steppacher Law Offices LLC. All Rights Reserved.
The Personal Injury Center of AmericaTM is proud to serve clients in New York, Los Angeles, Chicago, Houston, Philadelphia, and throughout the nation.